{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:52:02Z","timestamp":1791867122315,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009580","name":"Chinese PLA General Hospital","doi-asserted-by":"publisher","award":["22QNCZ023"],"award-info":[{"award-number":["22QNCZ023"]}],"id":[{"id":"10.13039\/501100009580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.iliver.2024.100094","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T21:58:28Z","timestamp":1713909508000},"page":"100094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"3","author":[{"given":"Qian-Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-462X","authenticated-orcid":false,"given":"Dong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Fang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.iliver.2024.100094_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10290","key":"10.1016\/j.iliver.2024.100094_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.iliver.2024.100094_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.iliver.2022.09.001","article-title":"MAFLD was more easily diagnosed than NAFLD in liver transplant recipients with abnormal liver function","volume":"1","author":"Zhang","year":"2022","journal-title":"iLIVER"},{"issue":"6","key":"10.1016\/j.iliver.2024.100094_bib4","first-page":"931","article-title":"Nonalcoholic fatty liver disease (NAFLD) Name change: requiem or reveille?","volume":"9","author":"Singh","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"11","key":"10.1016\/j.iliver.2024.100094_bib5","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.3390\/nu12113501","article-title":"Metabolic syndrome: past, present and future","volume":"12","author":"Lemieux","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.iliver.2024.100094_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.iliver.2024.100094_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.iliver.2024.100094_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.iliver.2024.100094_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.iliver.2024.100094_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice","volume":"33","author":"Te","year":"2019","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.iliver.2024.100094_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.iliver.2024.100094_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100094_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research","volume":"32","author":"Kleiner","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.iliver.2024.100094_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.iliver.2024.100094_bib15","first-page":"609","article-title":"Expert consensus on obesity prevention and treatment in China","volume":"43","year":"2022","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.iliver.2024.100094_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.iliver.2024.100094_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100094_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.iliver.2024.100094_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.iliver.2024.100094_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/diagnostics13040614","article-title":"The link between NAFLD and metabolic syndrome","volume":"13","author":"Radu","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.iliver.2024.100094_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/metabo13010012","article-title":"Comparison of the three most commonly used metabolic syndrome definitions in the Chinese population: a prospective study","volume":"13","author":"Huang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.iliver.2024.100094_bib22","article-title":"Metabolic liver disease in diabetes\u2014from mechanisms to clinical trials","volume":"111S","author":"Dewidar","year":"2020","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.iliver.2024.100094_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2024.100094_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","author":"Kim","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.iliver.2024.100094_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.iliver.2022.02.001","article-title":"Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?","volume":"1","author":"Gong","year":"2022","journal-title":"iLIVER"},{"issue":"3","key":"10.1016\/j.iliver.2024.100094_bib26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.iliver.2024.100094_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17474124.2022.2137488","article-title":"Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival","volume":"16","author":"Eshraghian","year":"2022","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2024.100094_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12876-022-02430-7","article-title":"The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database","volume":"22","author":"Alkhouri","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.iliver.2024.100094_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.32074\/1591-951X-242","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"113","author":"Cataldo","year":"2021","journal-title":"Pathologica"},{"issue":"6","key":"10.1016\/j.iliver.2024.100094_bib30","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/jgh.15353","article-title":"A\u00a0review of non-alcoholic fatty liver disease in non-obese and lean individuals","volume":"36","author":"Ahadi","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.iliver.2024.100094_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.iliver.2024.100094_bib32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00535-021-01833-9","article-title":"Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review","volume":"56","author":"Kamada","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"issue":"1129","key":"10.1016\/j.iliver.2024.100094_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/postgradmedj-2018-136364","article-title":"Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Amanullah","year":"2019","journal-title":"Postgrad Med"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947824000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T04:15:36Z","timestamp":1719288936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947824000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2772947824000197"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100094","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2024.100094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100094"}}